mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.7 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |